These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Statins on trial. Pfizer faces clot of lawsuits that claim Lipitor caused women's diabetes. Carlson J Mod Healthc; 2014 May; 44(20):20-2. PubMed ID: 25055462 [No Abstract] [Full Text] [Related]
45. Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis. Sellner J; Greeve I; Leib SL; Mattle HP Arch Neurol; 2008 May; 65(5):672-4. PubMed ID: 18474748 [No Abstract] [Full Text] [Related]
47. Autoimmune hepatitis revealed by atorvastatin. Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804 [TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F; Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729 [TBL] [Abstract][Full Text] [Related]
49. A possible negative effect of co-administered amlodipine and atorvastatin on semen volume and spermatozoa in men. Cai T; Mondaini N; Mazzoli S; Bartoletti R J Pharm Pharmacol; 2008 Nov; 60(11):1431-2. PubMed ID: 18957162 [No Abstract] [Full Text] [Related]
55. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
57. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Wenger NK; Lewis SJ; Welty FK; Herrington DM; Bittner V; Heart; 2008 Apr; 94(4):434-9. PubMed ID: 18070940 [TBL] [Abstract][Full Text] [Related]
58. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470 [TBL] [Abstract][Full Text] [Related]
59. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia. Lam HC; Chu CH; Wei MC; Keng HM; Lu CC; Sun CC; Lee JK; Chuang MJ; Wang MC; Tai MH Exp Biol Med (Maywood); 2006 Jun; 231(6):1010-5. PubMed ID: 16741040 [TBL] [Abstract][Full Text] [Related]
60. Irreversible atorvastatin-associated hearing loss. Liu M; Alafris A; Longo AJ; Cohen H Pharmacotherapy; 2012 Feb; 32(2):e27-34. PubMed ID: 22392429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]